Orthofix Medical Inc operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Orthofix Medical Inc with three other
medical equipment manufacturers in Europe:
Consort Medical Plc
of the United Kingdom
sales of £311.10 million [US$399.87 million]
of which 59%
Ypsomed Holding AG
(466.12 million Swiss Francs [US$470.83 million]
of which 68%
was Delivery Devices), and
based in Denmark
(2.61 billion Danish Kroner [US$383.86 million]
of which 36%
Orthofix Medical Inc reported sales of 384.50 million Euro (US$422.99 million)
December of 2018.
a very small
increase of 1.0%
versus 2017, when the company's sales were 380.84 million Euro.
Sales at Orthofix Medical Inc have increased during each of the previous five years
(and since 2013, sales have increased a total of 28%).
Sales of Spine Fixation saw an increase
that was more than double the company's growth rate: sales were up
8.1% in 2018, from
71.95 million Euro to 77.79 million Euro.
Orthofix Medical Inc also saw significant increases in sales in
Biostim (up 1.5% to 165.71 million Euro)
Not all segments of Orthofix Medical Inc experienced an increase in sales in 2018:
sales of Biologics fell 8.0% to 50.65 million Euro.
Orthofix Medical Inc also experienced decreases in sales in
Extremity Fixation (down 0.3% to 90.34 million Euro)